Community Acquired Pneumonia (CAP): Clinical Trials

1 trial for Community Acquired Pneumonia (CAP), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Community Acquired Pneumonia (CAP): new trials by email Literature Review of Community Acquired Pneumonia (CAP) trials Research Report on Community Acquired Pneumonia (CAP)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Local Antibiotic Delivery for Community Acquired Pneumonia
Levofloxacin, Placebo - Community Acquired Pneumonia (CAP)
Phase 2 / Phase 3Not yet recruitingCopenhagen Respiratory Research362025-03-042025-03-10

Narrower conditions

Asthma (1)  ·  Community-Acquired Pneumonia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Bronchial Diseases (1)  ·  Chronic Disease (1)  ·  Community-Acquired Infections (1)  ·  Disease Attributes (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Respiratory Hypersensitivity (1)  ·  Respiratory Tract Diseases (1)

Interventions

Levofloxacin (1)

Sponsors

Copenhagen Respiratory Research (1)

Top investigators

Jens-Ulrik S. Jensen, Professor, MD, phD (1)